HOME >> BIOLOGY >> NEWS
Protein stops blood-vessel growth, holds promise as cancer therapy

Researchers at National Jewish Medical and Research Center have identified a protein that inhibits the formation of new blood vessels.

Combined with previous findings that the protein is depleted or missing in a majority of metastatic human cancers, the findings suggest that fibulin-5 may one day be an effective cancer therapy. William Schiemann, Ph.D., Assistant Professor in the Program in Cell Biology at National Jewish, and postdoctoral fellow Allan R. Albig reported their findings in the June issue of DNA and Cell Biology.

"We believe fibulin-5 shows real promise as a cancer therapy," said Schiemann. "When we slightly altered the naturally occurring protein it was even more effective at inhibiting the sprouting of new blood vessels."

Cancer tumors need nutrients and oxygen supplied by blood vessels in order to grow. They also use blood vessels to spread to other parts of the body.

This process, known as metastasis, is the most lethal characteristic of cancer and the leading cause of cancer-related death. The strategy of fighting cancer by preventing the growth of new blood vessels has generated great interest in recent years, with the first antiangiogenic drug being approved earlier this year.

Endothelial cells have been the target of most antiangiogenic strategies. Endothelial cells are specialized cells that develop into blood vessels. Fibulin-5, a member of a family of extracellular matrix proteins that regulate tissue development, remodeling and repair, interacts with endothelial cells.

In cell culture studies, Schiemann and Albig showed fibulin-5 levels drop significantly when endothelial cells begin to form blood vessels, a process known as tubulation. They also show that high levels of fibulin-5 could prevent the sprouting of new blood vessels by inhibiting the proliferation and movement of endothelial cells.

Fibulin-5 interfered with signaling by the proangiogenic factor VEGF, and increased level
'"/>

Contact: William Allstetter
allstetterw@njc.org
303-398-1002
National Jewish Medical and Research Center
18-Jun-2004


Page: 1 2

Related biology news :

1. Protein is key to fatal disorder and normal cell function
2. Protein is key for digestive function of the pancreas
3. Proteins show promise for mosquito control
4. Protein involved in childhood disorder linked to cancer
5. Protein fishing in America: The movie
6. Protein vaccine fully protects mice from lethal aerosol challenge with ricin toxin
7. Protein key to trafficking in nerve terminals
8. Protein controls acid in cells by direct detection of volume changes, study finds
9. Protein believed to control formation of memory identified by Scripps & UCSD scientists
10. Proteins transform DNA into molecular velcro
11. Protein engineered to detect nerve gas

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/14/2019)... ... August 14, 2019 , ... An upcoming episode of ... microbiome therapeutics are helping to promote normal immune function in order to prevent ... educate about the DECODE.DESIGN.CURE™ technology platform, which rapidly develops microbiome therapeutics in order ...
(Date:8/14/2019)... ... ... Representatives with MyBioGate announced that China Focus@Biotech Week will be held September 10 ... connect with Chinese pharma and investors in healthcare innovation,” said Miao Guo, Vice President ... a part of Biotech Week Boston – the annual biotech festival at the No. ...
(Date:8/14/2019)... ... 13, 2019 , ... Dr. Julie Reck of Veterinary Medical Center of Fort Mill ... first stem cell patient, her own geriatric Australian Shepherd, Simon, was treated in June 2019 ... to play but his body was weak, and he struggled to play fetch and other ...
Breaking Biology News(10 mins):
(Date:9/17/2019)... Calif. (PRWEB) , ... September 17, 2019 , ... Tucker, ... osteoarthritis. At only four months old, Tucker was limping and lame on his right ... and elbow dysplasia and it was called “the worst case the vet had seen.” ...
(Date:9/17/2019)... ... September 16, 2019 , ... MyBioGate ... China Focus @ Biotech Week Boston, a forum organized by MyBioGate, Inc. and ... innovation. , After a careful process of evaluation, twelve companies out of over ...
(Date:9/9/2019)... ... 09, 2019 , ... Visikol CEO Dr. Michael Johnson recently gave a ... to characterize 3D cell culture models. The inherent problem of characterizing 3D cell culture ... to image through and therefore traditional wide-field or even confocal microscopy only tells you ...
(Date:8/29/2019)... , ... August 29, 2019 , ... ... disease affecting grapevines, a feat they hope will ultimately help protect the multibillion-dollar ... including several Rochester Institute of Technology faculty and alumni sequenced the microbiome found ...
Breaking Biology Technology:
Cached News: